Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002241428 | SCV001399781 | uncertain significance | Typical absence seizure; Myoclonic epilepsy, juvenile, susceptibility to, 1 | 2019-10-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile430Asnfs*24) in the EFHC1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs752642262, ExAC 0.01%). This variant has not been reported in the literature in individuals with EFHC1-related conditions. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in EFHC1 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV004554851 | SCV005044039 | uncertain significance | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | PM2 |